TENAX THERAPEUTICS, INC. Total Liabilities and Equity
TENAX THERAPEUTICS, INC. (TENX) had Total Liabilities and Equity of $121.66 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-07-31
- 2026-06-30: Liabilities and Equity $121.66M.
- 2026-03-31: Liabilities and Equity $123.18M.
- 2025-12-31: Liabilities and Equity $104.23M.
- 2025-09-30: Liabilities and Equity $102.81M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $121.66M 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $123.18M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $104.23M 10-Q · filed 2026-07-31 | |
| 2025-09-30 | $102.81M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $105.86M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $112.06M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $96.69M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $99.78M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $10.62M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $14.46M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $11.69M 10-K · filed 2025-03-25 | $11.68M 10-K · filed 2024-03-28 |
| 2023-09-30 | $11.89M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $14.05M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $15.27M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $3.40M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $4.74M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $8.36M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $3.74M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $5.99M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $8.91M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $2.89M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $4.56M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $6.87M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $9.00M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $5.35M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $5.95M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $6.37M 10-K/A · filed 2021-04-16 | |
| 2019-09-30 | $7.77M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $9.66M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $11.46M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $13.34M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $5.45M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $7.03M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $8.31M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $9.89M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $11.00M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $13.45M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $19.15M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $23.34M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $59.71M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $64.13M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $69.54M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $72.99M 10-K · filed 2017-03-16 | |
| 2015-10-31 | $75.45M 10-Q · filed 2015-12-10 | |
| 2015-07-31 | $78.59M 10-Q · filed 2015-09-09 | |
| 2015-04-30 | $82.91M 10-KT · filed 2016-03-14 | |
| 2015-01-31 | $86.19M 10-Q · filed 2015-03-17 | |
| 2014-10-31 | $89.22M 10-Q · filed 2014-12-15 | |
| 2014-07-31 | $91.40M 10-Q · filed 2014-09-15 | |
| 2014-04-30 | $93.43M 10-KT · filed 2016-03-14 | |
| 2014-01-31 | $33.94M 10-Q · filed 2014-03-17 | |
| 2013-10-31 | $4.36M 10-Q · filed 2013-12-17 | |
| 2013-07-31 | $5.89M 10-Q · filed 2013-09-17 | |
| 2013-04-30 | $3.18M 10-K · filed 2014-07-29 | |
| 2013-01-31 | $3.04M 10-Q · filed 2013-03-18 | |
| 2012-10-31 | $3.54M 10-Q · filed 2012-12-14 | |
| 2012-07-31 | $5.13M 10-Q · filed 2012-09-19 | |
| 2012-04-30 | $4.14M 10-K · filed 2013-06-26 | |
| 2012-01-31 | $5.89M 10-Q · filed 2012-03-15 | |
| 2011-10-31 | $4.55M 10-Q · filed 2011-12-15 | |
| 2011-07-31 | $6.18M 10-Q · filed 2011-09-19 | |
| 2011-04-30 | $2.92M 10-K · filed 2012-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |